These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29158064)

  • 81. Growth inhibitory effects of three miR-129 family members on gastric cancer.
    Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
    Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma.
    Soldini D; Valera A; Solé C; Palomero J; Amador V; Martin-Subero JI; Ribera-Cortada I; Royo C; Salaverria I; Beà S; Gonzalvo E; Johannesson H; Herrera M; Colomo L; Martinez A; Campo E
    Am J Surg Pathol; 2014 Jan; 38(1):86-93. PubMed ID: 24145648
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 84. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.
    Balsas P; Veloza L; Clot G; Sureda-Gómez M; Rodríguez ML; Masaoutis C; Frigola G; Navarro A; Beà S; Nadeu F; Giné E; López-Guillermo A; Martínez A; Ribera-Cortada I; Engel P; Quintanilla-Martínez L; Klapper W; Campo E; Amador V
    Blood; 2021 Dec; 138(22):2202-2215. PubMed ID: 34189576
    [TBL] [Abstract][Full Text] [Related]  

  • 85. What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
    Witzig TE
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):825-835. PubMed ID: 32861280
    [TBL] [Abstract][Full Text] [Related]  

  • 86. miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.
    Kawaji-Kanayama Y; Tsukamoto T; Nakano M; Tokuda Y; Nagata H; Mizuhara K; Katsuragawa-Taminishi Y; Isa R; Fujino T; Matsumura-Kimoto Y; Mizutani S; Shimura Y; Taniwaki M; Tashiro K; Kuroda J
    Cancer Sci; 2024 Feb; 115(2):452-464. PubMed ID: 38050664
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions.
    Gallucci Figorelle L; Galvão PT; de Lima FMR; Marimon P; Pentagna N; Milito C; Schaffel R; Carneiro K
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):433-445. PubMed ID: 38641485
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
    Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
    Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
    [TBL] [Abstract][Full Text] [Related]  

  • 89. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Expanded clinical and experimental use of SOX11 - using a monoclonal antibody.
    Nordström L; Andréasson U; Jerkeman M; Dictor M; Borrebaeck C; Ek S
    BMC Cancer; 2012 Jun; 12():269. PubMed ID: 22738398
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis.
    Lee W; Shin E; Kim BH; Kim H
    PLoS One; 2019; 14(11):e0225096. PubMed ID: 31714947
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
    Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
    Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
    Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
    Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
    [TBL] [Abstract][Full Text] [Related]  

  • 94. MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair.
    Li W; Xue W; Wang X; Fu X; Sun Z; Li Z; Chang Y; Zhang X; Zhou Z; Chen C; Zhang M
    Anticancer Drugs; 2018 Oct; 29(9):861-870. PubMed ID: 29979193
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material.
    Bentz JS; Rowe LR; Anderson SR; Gupta PK; McGrath CM
    Cancer; 2004 Apr; 102(2):124-31. PubMed ID: 15098257
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides.
    Schroers R; Hildebrandt Y; Steffens R; Becker S; Ohms G; von Bonin F; Haase D; Bertsch HP; Trümper L; Griesinger F
    Eur J Haematol; 2005 Jul; 75(1):78-84. PubMed ID: 15946316
    [TBL] [Abstract][Full Text] [Related]  

  • 97. PPAR
    Gao Y; Han D; Sun L; Huang Q; Gai G; Wu Z; Meng W; Chen X
    Biomed Res Int; 2018; 2018():3842753. PubMed ID: 29862267
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma.
    Condoluci A; Rossi D; Zucca E; Cavalli F
    Curr Oncol Rep; 2018 Aug; 20(10):79. PubMed ID: 30132080
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
    Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E
    Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.